Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
63 hedge funds and large institutions have $121M invested in Neos Therapeutics, Inc in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 14 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 12
37% more capital invested
Capital invested by funds: $88.5M → $121M (+$33M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 67 → 63 (-4)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
28% less call options, than puts
Call options by funds: $466K | Put options by funds: $647K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.41M |
| 2 |
Millennium Management
New York
|
+$3.61M |
| 3 |
BlackRock
New York
|
+$3.41M |
| 4 |
LSC
Lyon Street Capital
Sausalito,
California
|
+$1.71M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.13M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$1.59M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.39M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.33M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$1.09M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MAM
76
Meeder Asset Management
Dublin,
Ohio
| – | -$1K | -98 | Closed |
|
77
Bank of Montreal
Toronto,
Ontario, Canada
| – | +$46 | +6 | +300% |
|
NEOS Hedge Fund Activity: Q3 2017 in Review
63 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q3 2017, worth a combined $121M — up 37% from $88.5M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NEOS and 11 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 30 added.
The largest buyer was Cortina Asset Management, opening a new position worth an estimated $4.41M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $4.13M sold.
- 63 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q3 2017, down from 67 in Q2 2017.
- Funds reported $121M of Neos Therapeutics, Inc stock for Q3 2017, up 37% quarter-over-quarter.
- 11 funds opened new Neos Therapeutics, Inc positions in Q3 2017 and 14 closed out, a net change of -3 holders.
- The largest Neos Therapeutics, Inc buyer in Q3 2017 was Cortina Asset Management, an estimated $4.41M added.
- The largest Neos Therapeutics, Inc seller in Q3 2017 was Stonepine Capital Management, an estimated $4.13M sold.
Based on aggregated 13F filings for Q3 2017.